Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 18, 16:00
Apellis Pharmaceuticals Market Cap : 5.253B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.15B |
| Eli Lilly & Co. | 903.95B |
| Agios Pharmaceuticals, Inc. | 1.651B |
| Spyre Therapeutics, Inc. | 5.768B |
| Scholar Rock Holding Corp. | 5.681B |
Market Cap Related Metrics
| PE Ratio | 41.01 |
| PS Ratio | 4.772 |
| Price to Book Value | 12.66 |
| Price to Free Cash Flow | 140.77 |
| Price | 41.03 |
| Earnings Yield | 2.44% |
| Operating PE Ratio | 31.92 |
| Normalized PE Ratio | 41.01 |